**Core Concept**
L-asparaginase is an enzyme used in the treatment of acute lymphoblastic leukemia (ALL), a type of cancer that originates from the lymphoid cells of the bone marrow. This enzyme works by depleting the amino acid asparagine, which is essential for the growth and survival of lymphoblasts.

**Why the Correct Answer is Right**
The correct answer is related to the mechanism of action of L-asparaginase. L-asparaginase is a pegylated form of the enzyme asparaginase, which is used to treat ALL. This enzyme depletes the amino acid asparagine, which is essential for the growth and survival of lymphoblasts. Patients with ALL often lack the enzyme asparagine synthetase, which is necessary to synthesize asparagine. Therefore, L-asparaginase is critical in treating ALL by depriving the cancer cells of asparagine.

**Why Each Wrong Option is Incorrect**
**Option A:** Acute myeloid leukemia (AML) is a type of cancer that originates from the myeloid cells of the bone marrow. While L-asparaginase can be used in AML, it is not the primary indication. AML is typically treated with other chemotherapeutic agents.

**Option B:** Chronic lymphocytic leukemia (CLL) is a type of cancer that originates from the lymphoid cells of the bone marrow. CLL is often treated with targeted therapies or chemotherapy, but L-asparaginase is not typically used.

**Option C:** Non-Hodgkin lymphoma (NHL) is a type of cancer that originates from the lymphoid cells of the lymph nodes. While NHL can be treated with a variety of chemotherapeutic agents, L-asparaginase is not a primary treatment option.

**Clinical Pearl / High-Yield Fact**
L-asparaginase is a critical component of the treatment regimen for acute lymphoblastic leukemia (ALL). Its mechanism of action involves depleting the amino acid asparagine, which is essential for the growth and survival of lymphoblasts.

**Correct Answer:** C.